BiotechTube

SAL-0951 + Placebo

Phase 3Completed
0 watching 0 views this week๐Ÿ“ˆ Rising
76
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Renal Anemia in Non-dialysis Chronic Kidney Disease

Conditions

Renal Anemia in Non-dialysis Chronic Kidney Disease

Trial Timeline

Dec 8, 2020 โ†’ Feb 21, 2022

NCT ID
NCT06016036

About SAL-0951 + Placebo

SAL-0951 + Placebo is a phase 3 stage product being developed by Shenzhen Salubris Pharmaceuticals for Renal Anemia in Non-dialysis Chronic Kidney Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT06016036. Target conditions include Renal Anemia in Non-dialysis Chronic Kidney Disease.

Hype Score Breakdown

Clinical
27
Activity
18
Company
9
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT06016036Phase 3Completed

Competing Products

20 competing products in Renal Anemia in Non-dialysis Chronic Kidney Disease

See all competitors
ProductCompanyStageHype Score
MBX 2109 + MBX 2109 + MBX 2109 + MBX 2109MBX BiosciencesPhase 1
28
LY3473329Eli LillyPhase 1
33
Tildacerfont/PlaceboSpruce BiosciencesPhase 2
44
SPR001Spruce BiosciencesPhase 2
44
SPR001Spruce BiosciencesPhase 2
44
Tildacerfont/PlaceboSpruce BiosciencesPhase 2
44
TildacerfontSpruce BiosciencesPhase 2
44
Drotrecogin alfa activated (Xigris)Eli LillyPhase 2
52
LY3819469Eli LillyPhase 1
33
Atezolizumab + CabozantinibChugai PharmaceuticalPhase 3
77
DS-6000a + DS-6000aDaiichi SankyoPhase 1
33
DS-1093aDaiichi SankyoPhase 1
33
CS-3150Daiichi SankyoPhase 3
77
AGS-16C3FAstellas PharmaPhase 1
33
AGS-16M8FAstellas PharmaPhase 1
33
CP-461Astellas PharmaPhase 2
52
roxadustatAstellas PharmaPhase 3
77
YM178Astellas PharmaPhase 1
33
intravenous immunoglobulins (IVIG)Astellas PharmaPhase 1
33
bixalomerAstellas PharmaPre-clinical
23

Other Products from Shenzhen Salubris Pharmaceuticals

Allisartan Isoproxil Tablets 240mg or placebo + Allisartan Isoproxil Tablets 480mg or placebo + Allisartan Isoproxil Tablets 720mg or placeboApproved
84
Enarodustat 2mg + Enarodustat 3mg + Enarodustat 4mgApproved
84
ClopidogrelApproved
84
SAL056 (56.5ฮผg) + AlendronatePhase 3
76
SAL067 + Alogliptin + PlaceboPhase 3
76